As of July 1, 2025, advertisers in the U.S., Canada, and New Zealand must now apply for the Restricted Drug Term Personalization Certification to use Google Ads personalization tools when promoting products or services containing Restricted Drug Terms to healthcare professionals.
Without this certification, personalized targeting for such products won’t be allowed. Advertisers outside these countries aren’t eligible to apply due to regulatory limitations.
Read the full update here: Restricted Drug Term Personalization Certification Application.